DRG对原发性支气管肺癌临床路径实施效果的优化研究  

Research on Optimization of Clinical Pathway Effect of DRG:Based on Primary Bronchial Lung Cancer

作　　者：邱晶青 汤天凤[2] 薛缪群[2] 孙蓉蓉[2] 韩光曙[2] Qiu Jingqing;Tang Tianfeng;Xue Miaoqun;Sun Rongrong;Han Guangshu(Institute for Hospital Management of Tsinghua University,Beijing,100084;The Affiliated Drum Tower Hospital of Nanjing University Medical School,Nanjing,Jiangsu,210008)

机构地区：[1]清华大学医院管理研究院,北京100084 [2]南京大学医学院附属鼓楼医院,江苏南京210008

出　　处：《江苏卫生事业管理》2018年第9期1033-1037,共5页Jiangsu Health System Management

基　　金：南京医学科技发展重点项目(ZKX160047);南京大学医院管理研究所基金(NDYG2016009)

摘　　要：目的:分析某三甲医院原发性支气管肺癌临床路径的实施效果,探索临床路径优化策略。方法:选择2016年收治的572例原发性支气管肺癌患者,其中314例为临床路径入径组,其余258例为未入径组,比较优化前后入径组和未入径组的性别、年龄、平均住院日、住院费用等。结果:按DRG分组细化临床路径管理后,住院费用管理较分组前有了较大的提升。结论:本次优化策略证明有效。Objective:To analyze the implementation of the clinical pathway of primary bronchial lung cancer in a Tertiary Level A hospital and to explore the optimization strategies.Method:314 out of 572 patients with primary bronchial lung cancer who were admitted via clinical pathways were classified as intake group,and 258 were classified non-intake group.The gender,age,average length of stay,cost were compared before and after optimization between intake group and non-intake group.Results:After refining the clinical pathway using DRG,the management of cost was greatly improved.Conclusion:The optimization strategies proved effective.

关 键 词：临床路径 DRG 费用管理 原发性支气管肺癌 

分 类 号：R197.1[医药卫生—卫生事业管理]